Vulvar cancer forms in the outer part of the female genitals. The vulva includes the opening of the vagina, skin folds around the vagina (the labia majora and the labia minora) and the clitoris. Vulvar cancer most often occurs on the inner edges of the labia.
Vulvar cancer usually forms slowly over many years. Abnormal cells can grow on the surface of the vulvar skin for a long time. This condition is called vulvar intraepithelial neoplasia (VIN). If left untreated, VIN can develop into cancer.
Vulvar cancers are very rare, and while all women are at risk for these cancers, very few will get them. According to the Centers for Disease Control and Prevention, vaginal and vulvar cancers combined account for 6-7 percent of all gynecologic cancers diagnosed in the United States.
There is no reliable way to test for vulvar cancers in women before they experience signs or symptoms. A woman’s best defense is knowing her own body and paying attention to potential signs, listed below, then visiting her doctor for a biopsy.
When found early, vulvar cancers are highly treatable.
There are a number of types of vulvar cancer, although squamous cell carcinoma is by far the most common. A gynecologic oncologist can determine the type by performing a biopsy.
Squamous cell carcinoma: This wart-like growth is the most common type of vulvar cancer. It may take several years before growth develops into cancer.
Melanoma: This skin cancer is the second most common type of vulvar cancer, occurring in about 4 out of every 100 vulvar cancers. It is most often found in women older than 50, and Caucasian women are at higher risk of developing vulvar melanoma.
Sarcomas: These fast-growing but rare cancers start in tissue such as muscle or fat under the skin. These cancers tend to grow quite quickly and are found in both children and adults.
Adenocarcinoma: A small number of vulvar cancers called adenocarcinomas (about 8 percent) develop from sweat glands in the vulvar skin. Paget’s disease of the vulva is a condition where adenocarcinoma cells spread out from these glands and across the skin of the vulva.
Basal cell carcinoma: A small number of vulvar cancers are basal cell carcinomas, which develop from basal cells— the deepest layer of skin cells.
As is the case with other cancers, there are few definitive causes for vulvar cancer, though several genetic and lifestyle factors can increase the risk of developing vulvar cancer. These risk factors include:
Most women with vulvar cancer show no apparent signs and symptoms. Generic symptoms of vulvar cancer can include:
Symptoms may be caused by something other than cancer, but the only way to know is to see a doctor if any of these symptoms occur.
The only way to diagnose vulvar cancer is to perform a biopsy. Even when a woman is showing signs or symptoms, it doesn’t necessarily mean she has vulvar cancer, as many symptoms overlap with other conditions.
During a biopsy, a physician will take a small piece of tissue from the vaginal area to be examined under the microscope. If the cancerous area is small, it may be completely removed (called an excisional biopsy) with a scalpel. Sometimes stitches are needed.
A biopsy determines if cancer or a pre-cancerous condition is present and, if so, what type it is.
Rarely, a doctor may use a dye test (painting the vulva with toluidine blue) to find areas of abnormal vulvar skin and to select the areas to biopsy. This dye causes skin with certain diseases, such as vulvar cancer, to turn blue.
Depending upon the cancerous results, further testing may be necessary. These tests can include:
Surgery is the most common form of vulvar cancer treatment, although radiation and chemotherapy are often used in conjunction with surgery in advanced stages. The type of surgery used depends on balancing sexual function importance with the need to remove all the cancer. The goal of surgery is to remove all the cancer without any loss of the woman’s sexual function or sensation.
Common surgical procedures to treat vulvar cancer include:
Surgery alone may not be enough in treating some forms of vulvar cancer. Some patients may undergo chemotherapy or radiation following the initial surgery in order to remove any remaining cancer cells. These treatments, known as adjuvant therapy, reduce the chances that the cancer will return.
Recovery time varies according to the type of surgery and how extensive it was. For extensive operations, such as a pelvic exenteration, it may be many weeks or months before a patient fully recovers.
As with any surgery, possible risks include infection, bleeding, scarring and blood clots.
Women who have had a vulvectomy or pelvic exenteration may also experience altered sensation in their vulva and difficulties reaching orgasm. Reconstructive surgery to rebuild the inner or outer lips of the genitals may also be an option for those women who have had more extensive operations.
Some of the decreased sensitivity is caused by nerve damage during surgery which may heal over time, although very slowly.
A gynecologic oncologist (a special cancer doctor trained to diagnosis and perform surgery on reproductive cancers) will walk patients through possible risks associated with different procedure options. They will also determine the best treatment path for individual patients based on their health, cancer stage and reproductive goals.
Learn about the innovative treatment options and research trials being offered at CU Anschutz.
Learn about the innovative treatment options and research trials being offered at CU Anschutz.